Heart Podcast
BMJ Group
The Heart Podcast is your go-to source for the latest insights and developments in cardiovascular medicine. Each episode features in-depth interviews with renowned authors and leading experts in the field, delving into the latest advances in cardiovascular research and treatments.Heart - heart.bmj.com - is a renowned international journal from the BMJ Group and the British Cardiovascular Society (BCS) dedicated to publishing research and reviews on cardiovascular disease. Stay ahead in your field by tuning into our expert discussions and accessing cutting-edge information.Subscribe now or listen on your favourite podcast platform to elevate your understanding of cardiovascular medicine. The Heart podcast is published twice a month, every other Tuesday.Podcast hosted by:Professor James Rudd, Professor of Cardiovascular Medicine and Consultant Cardiologist, University of Cambridge and Addenbrooke's Hospital, Cambridge.
Episodes
Mentioned books
Mar 25, 2014 • 12min
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease
This podcast discusses the 3rd Joint British Societies’ (JBS) consensus recommendations, released on 26th March 2014.
These eagerly anticipated guidelines incorporate much of the recent research in primary and secondary prevention of cardiovascular disease, and include a new risk calculator for physicians.
Heart’s social media editor, Dr Alistair Lindsay, discusses the most important points of the recommendations with Dr Iain Simpson, President of the British Cardiovascular Society and a member of the JBS 3 editorial group.
Mar 21, 2014 • 10min
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome
In this podcast, Philip Urban, Cardiovascular Department, Hôpital de La Tour, Geneva, discusses the Charlson Comorbidity Index (CCI).
Read the related paper:
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 http://goo.gl/Kjpj0l
Mar 21, 2014 • 13min
Long chain n-3 polyunsaturated fatty acids and coronary artery calcification in Japanese men
Coronary heart disease (CHD) is a major public health problem not only in developed but also in developing countries.1 CHD rates in Japan are uniquely low compared to the USA and other developed countries.
In a paper in April's Heart, Akira Sekikawa and colleagues from the University of Pittsburgh looked at whether serum concentrations of long chain n-3 polyunsaturated fatty acids (LCn3PUFAs) contribute to the difference in the incidence rate of coronary artery calcification (CAC) between Japanese men in Japan and white men in the USA.
Alistair Lindsay asks him what they found.
Read the full paper:
Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study http://goo.gl/rwKUCW
Mar 7, 2014 • 9min
Statins after acute coronary syndrome: a missed opportunity
Catherine Otto, Heart editor, talks to Greg Roth from the Division of Cardiology at University of Washington about his editorial which appears on heart.bmj.com and discusses prescription of statins after an acute myocardial infarction.
Feb 18, 2014 • 19min
Maintenance of statin use over 3 years following acute coronary syndromes
Dr Alistair Lindsay speaks to Dr Corina Grey, School of Population Health, University of Auckland, about her recent study looking at long-term adherence to statins in ACS patients.
Read the full paper: http://goo.gl/KF3NAK
Feb 18, 2014 • 24min
Aortic dilatation patterns and rates in adults with bicuspid aortic valves
Bicuspid aortic valve (BAV) is related to aortic dilatation, but patterns/rates are conflicting with no comparison among aneurysms of different aetiology.
In this podcast Alistair Lindsey talks to Hector Michelena from the Division of Cardiovascular Diseases at the Mayo Clinic about his research published in heart.bmj.com
Read the full research: http://heart.bmj.com/content/100/2/126.full
Dec 16, 2013 • 15min
Drs Bob Bonow and Catherine Otto discuss current issues in aortic valve stenosis
At the 2013 Uruguayan Society of Cardiology meeting in Montevideo, Dr Robert Bonow, Professor of Cardiology at Northwestern University Feinberg School of Medicine, gave a talk on aortic valve stenosis.
In this podcast he and Catherine Otto, discuss some of the new concepts in diagnosis and management of the condition.
Dec 2, 2013 • 19min
MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin
Read the full research onine: http://heart.bmj.com/content/99/22/1675
Dr Joao Lima, from the Division of Cardiology at Johns Hopkins Hospital in Balitmore, and colleagues set out to evaluate the benefit of niacin in addition to statin therapy on plaque regression among older individuals with established atherosclerosis.
They used MRI to more measure the plaque volume, and in this podcast Dr Lima explains to Laura Templer why that's a more accurate measure than the surrogates used in previous studies.
Dec 2, 2013 • 22min
Fatal venous thromboembolism associated with hospital admission
Read the full research online: http://heart.bmj.com/content/99/23/1734
In 2010, the Department of Health in England introduced an incentivised national target for National Health Service (NHS) hospitals aiming to increase the number of patients assessed for the risk of developing venous thromboembolism (VTE) associated with hospital admission.
Will Lester, from the Quality and Outcomes Research Unit at the University Hospital Birmingham, and colleagues assessed the impact of this initiative on VTE mortality and subsequent readmission with non-fatal VTE.
He joins Alistair Lindsey to talk about the study.
Nov 19, 2013 • 5min
Bone marrow derived cell therapy in ischemic cardiomyopathy
Catherine Otto, Heart's editor in chief, interviews April Stempien-Otero from the University of Washington, at the American Heart Association meeting in Dallas.
They discuss Dr Stempien-Otero's late breaking clinical trial, presented at the meeting, which looks at the use of bone marrow derived stem cells, and their use in ischemic cardiomyopathy with LVAD bridge to transfer.
